Product Comparison

Comparison Options

• Print
• Email
• Export Compare

					No Image
McKesson #	1109658	1236824	1155119	1155120	1140103
Description	Mozobil® Plerixafor 24 mg Injection 1.2 mL	Plerixafor 20 mg / mL Injection 1.2 mL	Nivestym® Filgrastim-aafi 300 mcg / 0.5 mL Injection 0.5 mL	Nivestym® Filgrastim-aafi 480 mcg / 0.8 mL Injection 0.8 mL	Zarxio® Filgrastim-sndz 480 mcg / 0.8 mL Injection 0.8 mL
Manufacturer #	00024586201	70121169402	00069029101	00069029201	61314032610
Brand	Mozobil®		Nivestym®	Nivestym®	Zarxio®
Manufacturer	Sanofi Aventis	Amneal Pharmaceuticals LLC	Pfizer Biosimilar	Pfizer Biosimilar	Sandoz
Invoice	MOZOBIL, VL 24MG/ML	PLERIXAFOR, SDV 20MG/ML 1.2ML	NIVESTYM, PFS 300MCG/0.5ML	NIVESTYM, PFS 480MCG/0.8ML	ZARXIO, PFS 480MCG/0.8ML (10/CT)
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number	2054708				3796828
Container Type	Single-Dose Vial	Single-Dose Vial	Prefilled Syringe	Prefilled Syringe	Prefilled Syringe
Generic Drug Code	16124	16124	45103	45104	38082
Generic Drug Name	Plerixafor	Plerixafor	Filgrastim-aafi	Filgrastim-aafi	Filgrastim-sndz
NDC Number	00024586201	70121169402	00069029101	00069029201	61314032610
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements			Requires Refrigeration	Requires Refrigeration	Requires Refrigeration
Strength	24 mg	20 mg / mL	300 mcg / 0.5 mL	480 mcg / 0.8 mL	480 mcg / 0.8 mL
Type	Subcutaneous	Subcutaneous	Intravenous or Subcutaneous	Intravenous or Subcutaneous	Intravenous or Subcutaneous
UNSPSC Code	51131520	51131520	51201802	51201802	51201802
Volume	1.2 mL	1.2 mL	0.5 mL	0.8 mL	0.8 mL
Application	Hematopoietic Agent	Hematopoietic Agent	Hematopoietic Agent	Hematopoietic Agent	Hematopoietic Agent
Country of Origin	Unknown	Unknown	Unknown	Unknown	Unknown
Dosage Form	Injection	Injection	Injection	Injection	Injection
Features and Benefits		Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma